Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system von EILERTSEN, Anette L, LIESTOL, Sigurd, MOWINCKEL, Marie-Christine, HEMKER, H. Coen, SANDSET, Per-Morten

Volltext

A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women von Dahm, Anders E.A, Eilertsen, Anette L, Goeman, Jelle, Olstad, Ole Kristoffer, Øvstebø, Reidun, Kierulf, Peter, Mowinckel, Marie-Christine, Skretting, Grethe, Sandset, Per Morten

Volltext

Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy von Opstad, Trine B, Eilertsen, Anette L, Høibraaten, Else, Skretting, Grethe, Sandset, Per Morten

Volltext

Hormone therapy and raloxifene reduce the coagulation inhibitor potential von Andresen, Marianne S, Eilertsen, Anette L, Abildgaard, Ulrich, Sandset, Per Morten

Volltext

Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level? von Negaard, Helene F S, Eilertsen, Anette L, Dahm, Anders, Iversen, Per O, Østenstad, Bjørn, Sandset, Per M

Volltext

Mechanisms of thrombosis related to hormone therapy von Sandset, Per Morten, Høibraaten, Else, Eilertsen, Anette Løken, Dahm, Anders

Volltext

Differential impact of conventional‐dose and low‐dose postmenopausal hormone therapy, tibolone and raloxifene on C‐reactive protein and other inflammatory markers von EILERTSEN, A. L., SANDVIK, L., STEINSVIK, B., SANDSET, P. M.

Volltext

The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis von Eilertsen, Anette Løken, Høibraaten, Else, Os, Ingrid, Andersen, Trine Opstad, Sandvik, Leiv, Sandset, Per Morten

Volltext